Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
Qingmiao Shao(Second Hospital of Tianjin Medical University), Tong Liu(Second Hospital of Tianjin Medical University), Gary Tse(Observational & Pragmatic Research Institute), Zhiwei Zhang, Guangping Li(Qingdao University), Yungang Zhao(Tianjin University of Sport), Lei Meng(Shandong University of Technology), Sharen Lee(University of Oxford), Mengqi Gong(Central South University), Jichao Zhao(University of Auckland)
Cited by 296
Related Papers
A global benchmark of algorithms for segmenting the left atrium from late gadolinium-enhanced cardiac magnetic resonance imaging
|Medical Image Analysis|2020|475
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393
Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion
|Journal of the American College of Cardiology|2007|271